Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,686
  • Shares Outstanding, K 30,348
  • Annual Sales, $ 71,350 K
  • Annual Income, $ -30,190 K
  • EBIT $ -28 M
  • EBITDA $ -26 M
  • 60-Month Beta 2.26
  • Price/Sales 0.43
  • Price/Cash Flow N/A
  • Price/Book 3.23

Options Overview Details

View History
  • Implied Volatility 296.70% ( -17.95%)
  • Historical Volatility 180.65%
  • IV Percentile 83%
  • IV Rank 33.80%
  • IV High 820.86% on 11/14/24
  • IV Low 29.10% on 06/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 57
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,018
  • Open Int (30-Day) 804

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.23
  • Low Estimate -0.28
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5200 +129.19%
on 11/12/24
1.2000 -0.68%
on 12/03/24
+0.1618 (+15.71%)
since 11/01/24
3-Month
0.5200 +129.19%
on 11/12/24
1.2000 -0.68%
on 12/03/24
+0.3268 (+37.78%)
since 09/03/24
52-Week
0.5200 +129.19%
on 11/12/24
5.0699 -76.49%
on 04/01/24
-0.8382 (-41.29%)
since 12/01/23

Most Recent Stories

More News
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

STIM : 1.1900 (+7.21%)
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

STIM : 1.1900 (+7.21%)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

STIM : 1.1900 (+7.21%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 4.82 (+0.21%)
STIM : 1.1900 (+7.21%)
PGY : 10.67 (-1.30%)
QSI : 1.1700 (+2.63%)
MNOV : 2.29 (-3.78%)
AXSM : 100.90 (+1.84%)
VSAT : 9.71 (-3.48%)
ZS : 198.07 (-5.01%)
BTM : 1.8150 (-0.82%)
RVPH : 1.1800 (-1.67%)
SPY : 603.83 (+0.03%)
XBI : 98.22 (-1.10%)
Neuronetics: Q3 Earnings Snapshot

Neuronetics: Q3 Earnings Snapshot

STIM : 1.1900 (+7.21%)
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

STIM : 1.1900 (+7.21%)
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call

STIM : 1.1900 (+7.21%)
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

STIM : 1.1900 (+7.21%)
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings

/CNW/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior...

STIM : 1.1900 (+7.21%)
GBNHF : 0.0120 (+4.35%)
STIM Stock Likely to Gain From Updated TMS Coverage

Neuronetics, Inc. STIM recently announced that additional payors have updated the coverage of TMS (transcranial magnetic stimulation). This upgrade is aimed at reducing the access barriers for patients...

AXGN : 14.18 (-2.61%)
STIM : 1.1900 (+7.21%)
TMDX : 72.36 (-15.01%)
KIDS : 26.20 (+1.04%)

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 1.3167
2nd Resistance Point 1.2233
1st Resistance Point 1.1667
Last Price 1.1900
1st Support Level 1.0167
2nd Support Level 0.9233
3rd Support Level 0.8667

See More

52-Week High 5.0699
Fibonacci 61.8% 3.3318
Fibonacci 50% 2.7950
Fibonacci 38.2% 2.2581
Last Price 1.1900
52-Week Low 0.5200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar